Items | Study groups (n = 25) | Control group (n = 33) | P value |
Success Unsuccess | 25 (100%) 0 (0%) | 32 (97%) 1 (3%) | 0.380 |
Duration of CA125 to normal level <1 week 1 week-2 weeks >2 weeks |
15 (60%) 7 (28%) 3 (12%) |
15 (45.5%) 13 (39.4%) 5 (15.2%) | 0.543 |
Disappearance of pain <1 months 2 - 5 months 6 - 12 months |
23 (92%) 2 (8%) 0 (0%) |
18 (54.5%) 13 (39.4%) 2 (6.1%) | 0.008 |
Menstruation cycle Normal Menorrhagia Amenorrhea |
24 (96%) 1 (4%) 0 (0%) |
19 (57.6%) 9 (27.3%) 5 (15.2%) | 0.004 |
Symptoms Related to medicine No any symptoms Nausea Vomiting Headache |
19 (76%) 5 (20%) 1 (4%) 0 (0%) |
13 (39.4%) 12 (36.4%) 5 (15.2%) 3 (9.1%) | 0.033 |
Renal Function Test Normal Dearranged |
23 (92%) 2 (8%) |
32 (97%) 1 (3%) | 0.397 |
Liver Function Test Normal Dearranged |
24 (96%) 1 (4%) |
25 (75.8%) 8 (24.2%) | 0.035 |
Ultrasound Reports Normal Small Collection in POD Recurrence |
24 (96%) 1 (4%) 0 (0%) |
32 (97%) 0 (0) 1 (3%) | 0.354 |
Pregnancy rate Natural Conception In vitro fertilization Not Conceived |
9 (36%) 9 (36%) 7 (28%) |
5 (15.2%) 8 (24.2%) 20 (60.6%) | 0.039 |